Inigo Les
Pamplona, NC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Branched-chain amino acids for people with cirrhosis and hepatic encephalopathy.
Journal: The Cochrane database of systematic reviews
Published: January 16, 2026
Low rather than high interleukin-6 levels are associated with immune-related adverse events in cancer patients treated with immune checkpoint inhibitors.
Journal: Frontiers in immunology
Published: August 01, 2025
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events.
Journal: Cancers
Published: January 31, 2023
Prediction of Immune-Related Adverse Events Induced by Immune Checkpoint Inhibitors With a Panel of Autoantibodies: Protocol of a Multicenter, Prospective, Observational Cohort Study.
Journal: Frontiers in pharmacology
Published: March 11, 2022
Association of immune-related adverse events induced by nivolumab with a battery of autoantibodies.
Journal: Annals of medicine
Published: June 01, 2021
Branched-chain amino acids for people with hepatic encephalopathy.
Journal: The Cochrane database of systematic reviews
Published: May 19, 2017
Duration of the acute hepatic encephalopathy episode determines survival in cirrhotic patients.
Journal: Therapeutic advances in gastroenterology
Published: May 04, 2017
Branched-chain amino acids for people with hepatic encephalopathy.
Journal: The Cochrane database of systematic reviews
Published: September 18, 2015
Branched-chain amino acids for people with hepatic encephalopathy.
Journal: The Cochrane database of systematic reviews
Published: February 26, 2015
Effectiveness and safety of medium-dose prednisone in giant cell arteritis: a retrospective cohort study of 103 patients.
Journal: Clinical and experimental rheumatology
Published: November 15, 2014
Last Updated: 09/26/2026